The analysis of nervous system disease mortality shows that in 2023, the United States leads with the highest recorded mortality, while Luxembourg has the lowest. Significant year-on-year increases are noted in countries like Colombia and Slovenia, while Spain, South Africa, and others see declines. Over the past five years, some countries exhibit modest increases, which indicates varying healthcare effectiveness worldwide.
Future trends to watch include potential shifts in global healthcare policies and technological advancements, which may impact the mortality rates of nervous system diseases. Population aging and lifestyle changes will also play crucial roles in shaping future trends.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 184,400 | 2023 | +5.06% | +6.55% | View data |
| 2 | 2 United Kingdom | 31,190 | 2023 | +5.43% | +5.9% | View data |
| 3 | 3 Brazil | 29,300 | 2023 | +4.42% | +5.33% | View data |
| 4 | 4 Spain | 15,240 | 2023 | -1.92% | -0.92% | View data |
| 5 | 5 South Korea | 9,540 | 2023 | +4.34% | +4.39% | View data |
| 6 | 6 Canada | 8,380 | 2023 | +1.15% | +0.91% | View data |
| 7 | 7 Finland | 7,290 | 2023 | +2.95% | +2.79% | View data |
| 8 | 8 Australia | 6,130 | 2023 | +3.56% | +4.45% | View data |
| 9 | 9 Netherlands | 4,930 | 2023 | +2.22% | -0.22% | View data |
| 10 | 10 Poland | 4,860 | 2023 | +4.16% | +6.38% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
